Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Astrocytoma × Vinblastine × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 32 Lymphoma 17 Urinary Bladder Neoplasms 8 Neoplasms 3 Melanoma 3 Leukemia 2 Glioma 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Urothelial Carcinoma of the Bladder 1 Skin Neoplasms 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pathologic Complete Response 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Mesothelioma, Malignant 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Neoplasms 1 Kidney Neoplasms 1 HIV Infections 1 Desmoid Tumors 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Brain Neoplasms 1

Interventions

Temozolomide 35 Radiotherapy 17 Bevacizumab 13 Magnetic Resonance Spectroscopy 9 Carmustine 9 Carboplatin 9 antineoplaston AS 2-1 8 antineoplaston A10 8 Irinotecan 7 Cyclophosphamide 6 Filgrastim 5 Cisplatin 5 sargramostim 4 Vincristine 4 Surgical Procedures, Operative 4 Specimen Handling 4 Everolimus 4 Etoposide 4 trametinib 3 Thalidomide 3 Sunitinib 3 Radiation 3 Procarbazine 3 Peripheral Blood Stem Cell Transplantation 3 Lomustine 3 FANG vaccine 3 Chemotherapy, Adjuvant 3 talampanel 2 palbociclib 2 dabrafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05180825 2025-08-08

PLGG - MEKTRIC

University Hospital, Strasbourg, France

Phase 2 Recruiting

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡